General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-11-14 | 2024-09 | -0.33 | N/A | N/A | N/A |
2024-08-08 | 2024-06 | -0.34 | -0.25 | 0.09 | 26.47% |
2024-05-09 | 2024-03 | -0.21 | -0.31 | -0.1 | -47.62% |
2024-05-09 | 2024-03 | -0.21 | N/A | N/A | N/A |
2024-03-14 | 2023-12 | 0 | N/A | N/A | N/A |
2024-03-14 | 2023-12 | 0 | -0.5 | N/A | N/A |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-08-13 | HC Wainwright & Co. | Upgrade | Neutral | Neutral |
2023-05-14 | HC Wainwright & Co. | Upgrade | Neutral | Neutral |
2023-03-19 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
2023-02-22 | HC Wainwright & Co. | Upgrade | Buy | |
2022-11-13 | HC Wainwright & Co. | Upgrade | Buy | |
2022-08-14 | HC Wainwright & Co. | Upgrade | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2021-05-23 | BENSON REED L | General Counsel | 3.17K | Conversion of Exercise of derivative security |
2024-05-22 | BROWN BRIAN LEE | Chief Financial Officer | 290.69K | Stock Award(Grant) |
2024-05-22 | DURENARD EUGENE A | Director | 115.00K | Stock Award(Grant) |
2024-05-22 | EGAN DWIGHT H. | Chief Executive Officer | 367.21K | Stock Award(Grant) |
2024-05-22 | MURPHY TED | Director | 127.50K | Stock Award(Grant) |
2024-05-22 | NELSON JAMES B | Director | 115.00K | Stock Award(Grant) |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Group Inc | 1.78M | 1.98M | 5.79% |
2023-06-29 | Renaissance Technologies, LLC | 653.70K | 725.61K | 2.12% |
2023-06-29 | Blackrock Inc. | 506.51K | 562.22K | 1.65% |
2023-06-29 | Geode Capital Management, LLC | 302.16K | 335.39K | 0.98% |
2023-06-29 | Bridgeway Capital Management, Inc. | 272.90K | 302.92K | 0.89% |
2023-06-29 | Bank Of New York Mellon Corporation | 145.62K | 161.64K | 0.47% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 1.28M | 1.42M | 4.15% |
2023-06-29 | Vanguard Extended Market Index Fund | 444.78K | 493.70K | 1.44% |
2023-06-29 | Bridgeway Funds Inc-Ultra Small Company Fund | 272.90K | 302.92K | 0.89% |
2023-05-30 | Fidelity Extended Market Index Fund | 165.22K | 180.09K | 0.54% |
2023-08-30 | iShares Micro Cap ETF | 69.84K | 86.60K | 0.23% |
2023-05-30 | Fidelity Total Market Index Fund | 53.59K | 58.41K | 0.17% |
30$ here we come
30$ here we come
Hint: Need Vaccine every year for whole world like flu shot.! Why? See bellow:
1: To save the people
2: To save Jobs
3: To save the business
4: To Save the Companies
5: To Save the cities
6: To save the Countries
7: To save the Continent
8: To save the World
9: To save the Economy
10: Save the planet
Note: if you would need painkiller with would you take same frequency as you are taking ??????
I would love $VXRT
Important note: Sorry who sold this morning and pre market.
In my opinion All cryptos will hit 50% + EOY. (Invest with your own risk/reward and DD).Get 10% bonus at following link in Binance . Their savings rate for USDT , BNB in more that 6.30%, bank rate is 0.05% !!!!!! Hahaha
https://accounts.binance.com/en/register?ref=NPF0TKH6
$CODX sorry, typo, that’s close to 1.8million shares, not $1.8million.
$CODX to clarify, Reagents, LLC is the seed capital that launched the ipo. The control person is Seth Egan, Dwight a part also. Seth is the communications Director for CODX. This filing simply shows a selling of shares by a debtor of the prior collateral, 25,000 shares, which satisfied the loan payoff. The important part is the filing shows the inside ownership of Reagents, LLC close to $1.8million worth, is still intact.
$CODX nice to know insiders still own roughly 1.8m shares. Actually a relief, given price action lately.
$ CODX the 50 day EMA actually. Today at $11.27
$CODX since September this has tested the downtrending 50 day MA 9 times, failed every time so far. Algo controlled. Gonna take news/volume to break trend.
$CODX Nope. Yet another red flag..to have to provide my email address to a stockbroker in order to be able to hear the call. Pathetic.
$CODX don’t excite too many too fast.
$CODX lessons for novice investors 101. Small caps: A CRL agreement news should be sold. Regardless of the potential.
$CODX “save money with CoPrimers” is actually not a bad subliminal hook, as ads go. It’s a net positive in this stock.
$CODX Pre-departure COVID-19 test now required in NZ
The new pre-departure testing requirements come into effect from 23:59pm (NZT) on 15 January 2021. Travellers from the United Kingdom or United States bound for New Zealand are required to have a negative test result for COVID-19 in the 72 hours before departure.
Infringement offences will apply to people arriving in New Zealand from the UK or the US without the required evidence. In the first two weeks (until 29 January 2021), the focus of enforcement action will be on education and compliance.
Pre-departure testing requirements will soon be expanded to all countries and territories excluding Australia, Antarctica and some Pacific Island nations.
All travellers, including anyone exempted from the pre-departure testing requirement, will still be required to complete the 14 days mandatory isolation which applies to all new arrivals into New Zealand